Furthermore, the expression of EPG5 was correlated with longer survival of lung cancer patients and silencing EPG5 significantly promoted NSCLC cells growth, and attenuated the pro-tumor growth effect of miR-150 in vitro and in vivo. This evidence concerns the gene EPG5 and neoplasm.